"Commodity exposure is probably the largest story here. Analysts should be paying close attention to that right now."
I may be reaching here, but I'm thinking the analysts surely have and are considering commodity exposure!
"watch n learn"
"three" words I wish I never read combined!
But since they are, I have found the posters who employ such a combo to be either insecure or egotistical, or both!
"...you would think that would be a cause of concern for people."
Perhaps some are more patient. Sure, it would be great if every stock we bought only rose afterwards, but that is not realistic. Heck, I've owned a stock, but have sold some shares, for fifteen years...bought at 11.50, in a few months, it went to 50 or so (sold some) and then proceeded to decline to around 21 cents (yes 21 cents) a few years later. Now it's trading around 110.
The "problem" with growth stocks is when there is a hint (or more) that the growth is slowing, the shares usually take a hit; that's one of the risks of investing in a growth company.
As long as WFM is not overweighted in your portfolio, you should be doing just fine given how the market has performed.
If you are patient and willing to hold WFM, IMO you will be rewarded. Of course, some people will sell a losing position once it has broken even; that's a zero sum game.
life changer, most likely, but not in the way you believe.
On the plus side, as you accumulate life experiences, you may become a more wise individual and investor!
Maybe, but the same scenario you described happened to a post of mine on another board, while on other boards, other posts made by me today have taken.
Any conspiracy theorists out there???
While I sold approx. 20% of my biotech position in January, after being long 10+ years, I pretty much concur with your "never" sell time frame. Of course, one should consider why they invested in the sector in the first place, and unless their circumstances have changed, I say buy and hold. Some day, when I'm looking for more income, I may sell some more, but for now, I'm looking for appreciation and I think this sector is a good place to invest SOME funds, but I wouldn't want to have biotech overweighted in my portfolio.
As you noted, a possible time to consider selling is when the portfolio manager departs.
Re "...the best biotech investor of our time...", while Kaul has done very well, you (and others) may be surprised how FBIOX has fared compared to IBB, iShares Biotech ETF.
IBB has outperformed FBIOX during the past
while FBIOX has outperformed IBB during the past 3 and 1 month periods.
Simply pull up the FBIOX chart and compare with IBB, using the above time frames.
Google "KMI short interest" and the first hit will be the NASDAQ site.
A/O 8/15, 51,941,723 KMI shares were short, up from 14.8M on 7/31.
Days to cover decreased from 7/31 because volume spiked...days to cover can be somewhat misleading
Trading volume has decreased since 8/15--it will be interesting to see 8/31's short interest
"who the broker is that has a $36 target."
Jefferies. Hold rating 8/7/14
Twelve month av target: 44.55 (11 of 18 analysts have price targets)
Who has the lone Sell rating? EVA Dimensions has an "underweight" rating 8/6/14.
"...they are out."
Perhaps. And perhaps those consumers will buy Tom's Toothpaste (owned by?)
Does the shampoo you use include Sodium Lauryl Sulfate (an ingredient that is banned in Europe & Central America???
Not sure why my earlier post didn't take; YahooF. can be fickle!
"I was talking with the head of sales at VAPE and was told..."
Did you speak with the "head of sales" on the phone or at a neighborhood barbecue?
I have to assume that whatever you were "told" is PUBLIC information, right?
Or should vape make a filing?
"...a buyback would have been the better alternative than the issuance of warrants."
Aren't a buyback and an issuance of warrants two different animals?
Buyback would take cash; issuance of warrants = non event unless the warrants are exercised
If exercised, more shares are would be outstanding while the company gets some cash.
Ignore is a good idea.
Why is she pumping such a large cap stock?
Is she simply trying to convince herself that she made the right trade?
She sure like to laugh a lot--rather bizarre.
I get that GSK yield significantly more than JNJ.
Do you get that you posted inaccurate info re the two companies' RSIs???